science top stories popular news  

Daily non-political popular news in brief.

Researchers design pulsed mircrojet system to deliver protein drugs without pain or bruising

03-06-2007 · EurekAlert!

A team of UCSB researchers, in collaboration with colleagues from UC Berkeley and StrataGent Life Sciences, of Los Gatos, Calif., has designed a novel pulsed microjet system engineered to deliver protein drugs into the skin without the pain or bruising that deeper penetration injection systems cause. The research was published online today in the Proceedings of the National Academy of Sciences.

Read more »

Keywords: researchers, design, pulsed, mircrojet, system, deliver, protein, drugs, pain, bruising, researcher, drug

« Previous | Next »

Similar news on "Researchers design pulsed mircrojet system to deliver protein drugs without pain or bruising":

  1. Man-made proteins could be more useful than real ones
    02-06-2007 · EurekAlert!
    Researchers have constructed a protein out of amino acids not found in natural proteins, forming a complex, stable structure closely resembling a natural protein. Their findings could help scientists design drugs that look and act like real proteins but won't be degraded by enzymes or targeted by the immune system, as natural proteins are.
    Similar news · Read more »
  2. Enzyme structure reveals new drug targets for cancer and other diseases
    02-14-2008 · EurekAlert!
    Researchers now have a clearer understanding of how a key protein controls gene activity and how mutations in the protein may cause disease. The work could provide new avenues to design drugs aimed at cancer, diabetes, HIV, and heart disease.
    Similar news · Read more »
  3. Key Function Of Nervous System Enzyme Found; Impact On Drug Development Against Alzheimer's
    09-29-2006 · ScienceDaily
    Ever since scientists first elucidated the molecular mechanisms underlying the pathology and loss of nerve cells in Alzheimer's disease, drug companies have been working to develop drugs which will inhibit the outbreak of this severe form of dementia. Now researchers in Munich and Berlin (Germany) have discovered that an enyzme which has a central causal role in Alzheimer's disease happens also to have a key function in the normal development of the nervous system. This enzyme, beta-secretase or BACE1, ensures that nerve fibers (axons) are adequately isolated with sheaths of myelin, enabling rapid conduction of electrical impulses, as well as preventing short-circuits, akin to plastic insulation on electrical wires.
    Similar news · Read more »
  4. Researchers discover possible markers for mental illness
    12-03-2007 · EurekAlert!
    Researchers have discovered natural genetic differences that might help predict the most effective antipsychotic drugs for particular patients with mental disorders such as schizophrenia, Parkinson's and drug addiction. They found the differences in the gene for a molecule called the dopamine D2 receptor, a protein present on brain cells that are sensitive to the neurotransmitter dopamine.
    Similar news · Read more »
  5. Protein inhibitor tangles with Alzheimer's disease
    02-15-2007 · EurekAlert!
    A hallmark of Alzheimer's disease (AD) is the abnormal accumulation of phosphorylated forms of a protein known as tau. In a new study, Mayo Clinic researchers have now shown in mice that a drug that inhibits the function of the protein Hsp90 (EC102) reduces the amount of phosphorylated tau in the brain. Unlike many drugs, EC102 is able to cross the blood-brain barrier, making it a highly promising therapeutic candidate for AD.
    Similar news · Read more »
  6. Protein found that may provide relief from neuropathic pain
    12-04-2007 · EurekAlert!
    Research in rodents by scientists from the UC-San Diego School of Medicine has provided evidence that a protein called LRP1 may help to ease neuropathic pain by blocking the response of glial cells that support and protect sensory neurons in the peripheral nervous system. Neuropathic pain is caused by injury to the peripheral nerves in diseases such as HIV/AIDS, shingles, and cancer or in repetitive motion disorders and trauma, and does not respond well to conventional pain-relieving drugs.
    Similar news · Read more »
  7. Researchers propose consumers buy yearly 'drug licenses' as new way to pay for prescriptions
    01-21-2008 · EurekAlert!
    Changing the way consumers pay for prescription drugs so that the system more closely resembles paying for cell phones or computer software could increase drug use without altering patients' out-of-pocket spending, health plan costs or drug company profits, according to researchers.
    Similar news · Read more »
  8. MIT model could predict cells' response to drugs
    07-30-2007 · EurekAlert!
    MIT researchers have developed a model that could predict how cells will respond to targeted drug therapies. Models based on this approach could help doctors make better treatment choices and drug developers identify the ideal compound. In addition, the model could help test the effectiveness of drugs for a wide range of diseases, including cancer, arthirtis, and immune system disorders.
    Similar news · Read more »
  9. Jefferson scientists identify protein key to breast cancer spread, potential new drug target
    04-09-2007 · EurekAlert!
    Researchers at the Kimmel Cancer Center at Jefferson have identified a protein that they say is key to helping a quarter of all breast cancers spread. The finding, reported online the week of April 9, 2007, in the journal Proceedings of the National Academy of Sciences, could be a potential target for new drugs aimed at stopping or slowing the growth and progression of breast cancer.
    Similar news · Read more »
  10. Drug eluting nanostructured coatings enable targeted drug therapy for orthopedic patients
    05-20-2007 · EurekAlert!
    Drug delivery systems have progressed from the teaspoon to time-release capsules to drug-eluting stents. Nanotechnology promises yet another advance by delivering therapeutic agents at desired rates exactly where needed in the body. In a paper presented at the NSTI Nanotech 2007 Conference, researchers at the University of California, San Francisco demonstrate how they have created nanotubes from biocompatible metal oxides that can hold therapeutic proteins or drugs and deliver these agents in a highly-controlled manner.
    Similar news · Read more »